Skip to main content Skip to section navigation Skip to footer
Back to checkpointtx.com

Checkpoint Therapeutics, Inc.

Investor Relations
  • Investors
  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents

Press Releases

News & Events

News & Events

  • Press Releases
  • IR Calendar
  • Email Alerts
Jul 02, 2024

Checkpoint Therapeutics Announces Biologics License Application Resubmission for Cosibelimab

Jun 24, 2024

Checkpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission

May 13, 2024

Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

May 10, 2024

Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates

Mar 22, 2024

Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Mar 18, 2024

Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors

Jan 29, 2024

Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market

Jan 11, 2024

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference

Dec 18, 2023

U.S. Food and Drug Administration Issues Complete Response Letter for Cosibelimab Solely Due to Inspection Findings at Third-Party Manufacturer

Dec 05, 2023

Checkpoint Therapeutics Strengthens Intellectual Property Protection for Cosibelimab with New U.S. Patent Issuance

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …13
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
©2025 Checkpoint Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap

Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.